news
Injectable tissue patch may help repair damaged organs
Researchers have developed a technique that lets them use a small needle to inject a repair patch, without the need to open the chest cavity...
List view / Grid view
Formulation
news
Experimental treatment for Niemann-Pick disease appears safe
An experimental drug has appeared to slow the progression of Niemann-Pick disease type C1...
news
NICE approves three quarters of drugs from the Cancer Drugs Fund
NICE has recommended sorafenib to be routinely available for patients on the NHS making it one of the 24 drugs appraised from the CDF...
news
Drug approval harmonisation shows savings potential
Researchers have compared the regulatory authorities responsible for approving drugs and medical products to verify their effectiveness and safety...
news
Report identifies two-tier pharmaceuticals market
A report released has identified a two-tier manufacturing market and forecast increased acquisitions by Indian companies...
news
Nexavar receives final appraisal for primary liver cancer
NICE has released a Final Appraisal Document recommending Nexavar for the treatment of patients with advanced hepatocellular carcinoma...
article
Risky endeavours for biosimilars market
Bringing a biosimilar from early development to market is a risky endeavour say Magnus Franzen (left) and Chris Isler, biosimilar experts at PA Consulting Group...
news
India’s pharmaceutical market set to hit $100bn by 2025
The future looks bright for India’s pharmaceutical environment says Vanaja Krishnan, Managing Director of George Clinical, India
news
Gold nanoparticles raise hopes for cancer treatments
Researchers have discovered properties of the precious metal that allow catalytic abilities to be accessed in living things without any side effects...
news
Compound derived from marijuana interacts with antiepileptic drugs
Cannabidiol is being studied as a potential anticonvulsant, and it has demonstrated effectiveness in animal models of epilepsy and in humans...
news
FDA approves AbbVie’s Mavyret for hepatitis C
The FDA has approved Mavyret to treat adults with chronic hepatitis C virus genotypes 1-6 without cirrhosis or with mild cirrhosis...
news
New injectable antiretroviral treatment for HIV patients
A phase II clinical trial has paved the way to the implantation of all-injectable antiretroviral therapies with a lower frequency of administration...
news
Artificial intelligence for human age-reversal
Insilico Medicine develops the advanced artificial intelligence algorithms to study the ageing processes and discover new interventions in ageing...
news
Uncovering the cause of immunotherapy resistance in tumours
Scientists have uncovered a key factor in the development of immunotherapy resistance in the case of cutaneous melanoma. This could potentially lead to future improvements in cancer therapy.
news
Double network hydrogels make drug-releasing systems safer
Double network hydrogel composed of two interwoven polymer nets to improve the safety of drug-delivery systems that reside within the stomach...
